Intevac (NASDAQ:IVAC) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.25) by 36 percent. This is a 1500 percent decrease over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $14.79 million which beat the analyst consensus estimate of $12.70 million by 16.48 percent. This is a 31.40 percent decrease over sales of $21.57 million the same period last year.
Goldman Sachs Initiates Coverage On Marsh & McLennan with Buy Rating, Announces Price Target of $182
Goldman Sachs analyst Robert Cox initiates coverage on Marsh & McLennan (NYSE:MMC) with a Buy rating and announces Price Target of $182.
